Aurobindo Pharma secures FDA approval for Fingolimod Capsules

Aurobindo Pharma secures FDA approval for Fingolimod Capsules

In a significant development for the pharmaceutical industry, Aurobindo Pharma Limited has announced receiving the final nod from the United States Food and Drug Administration (USFDA) to manufacture and market Fingolimod Capsules, 0.5 mg. This approval marks a crucial milestone, as these capsules are recognized as bioequivalent and therapeutically equivalent to the reference listed drug, […]

Mallinckrodt to acquire Sucampo Pharmaceuticals in $1.2bn deal

Mallinckrodt to acquire Sucampo Pharmaceuticals in $1.2bn deal

In a strategic move to broaden its pharmaceutical offerings, UK-based Mallinckrodt has announced the acquisition of Sucampo Pharmaceuticals, including its commercial and developmental assets, for approximately $1.2 billion. This acquisition also involves the assumption of $360 million of Sucampo’s debt, signaling a significant investment by Mallinckrodt into expanding its specialty pharmaceutical and rare disease sectors. […]

Novartis to acquire Advanced Accelerator Applications for $3.9bn to enhance oncology portfolio

Novartis to acquire Advanced Accelerator Applications for $3.9bn to enhance oncology portfolio

Novartis, the Switzerland-based global healthcare giant, has announced its decision to acquire Advanced Accelerator Applications (AAA), a French radiopharmaceutical company, for $3.9 billion. This acquisition is aimed at bolstering Novartis’ oncology platform, with a focus on expanding its portfolio with innovative nuclear medicine treatments. Details of the Acquisition and Expected Benefits Novartis will purchase all […]

Lupin expands US women’s health portfolio with $150m acquisition of Symbiomix Therapeutics

Lupin expands US women’s health portfolio with $150m acquisition of Symbiomix Therapeutics

Lupin Limited, a Mumbai-based generics pharmaceutical company, has strategically broadened its foothold in the women’s health sector by acquiring Symbiomix Therapeutics. The acquisition, valued at $150 million, was executed through Lupin’s US subsidiary, enhancing its presence in the specialized field of women’s health. Strategic Acquisition to Bolster Women’s Health Offerings Symbiomix Therapeutics, founded in 2012 […]

FDA approves Novo Nordisk’s Victoza for cardiovascular disease treatment in type 2 diabetes patients

FDA approves Novo Nordisk’s Victoza for cardiovascular disease treatment in type 2 diabetes patients

Novo Nordisk’s diabetes medication, Victoza (liraglutide), has gained U.S. Food and Drug Administration (FDA) approval for an expanded use, marking a significant step forward in the treatment of cardiovascular diseases among type 2 diabetes patients. This latest approval allows Victoza to be used to reduce the risk of major adverse cardiovascular events (MACE), including cardiovascular […]

Two dead, four injured in Vizag pharma city explosion

Two dead, four injured in Vizag pharma city explosion

Vizag fire accident news : A fire accident at the Jawaharlal Nehru Pharma City near Visakhapatnam on Tuesday left two employees dead and four injured who had survived burn injuries. The incident happened after a reactor exploded at one of the active pharmaceutical ingredient units at the Vizag pharma city, located about 50kms from Vizagat at […]

Sawai Pharmaceutical to acquire generic pharma business of Upsher-Smith

Sawai Pharmaceutical to acquire generic pharma business of Upsher-Smith

Japanese pharma company Sawai Pharmaceutical will acquire American generic drug maker Upsher‐Smith Laboratories’s generic pharma business for nearly $1.05bn from Acova. The generic drug portfolio of Upsher-Smith’s portfolio features over 30 pharma products which are primarily oral solid preparations. The transaction marks the first overseas acquisition for Sawai Pharmaceutical as per a report in the […]